IDEAS home Printed from https://ideas.repec.org/a/taf/rpsyxx/v12y2020i1p89-93.html
   My bibliography  Save this article

The case for including antipsychotics in the UK NICE guideline: “Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults”

Author

Listed:
  • R. E. Cooper
  • L. M. Grünwald
  • M. Horowitz

Abstract

The UK’s National Institute for Health and Care Excellence (NICE) is in the process of writing guidelines for “Medicines Associated with Dependence or Withdrawal Symptoms: Safe Prescribing and Withdrawal Management for Adults”. NICE has excluded antipsychotics, despite inclusion having been requested by all four groups participating in the guideline scoping workshop, as well as the Royal College of Psychiatrists, the All-Party Parliamentary Group for Prescribed Drug Dependence, the International Institute for Psychiatric Drug Withdrawal (IIPDW), Bangor University, Grünenthal Ltd, Pfizer and Mind (the UK’s largest mental health non-profit organisation). The IIPDW subsequently submitted the following request, drafted on their behalf by three researchers with expertise in this field, that NICE review its decision to exclude antipsychotics. The request draws on the recently updated German National Guideline for Schizophrenia. Two additional studies published since the submission, adding weight to the case, are also summarised.

Suggested Citation

  • R. E. Cooper & L. M. Grünwald & M. Horowitz, 2020. "The case for including antipsychotics in the UK NICE guideline: “Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults”," Psychosis, Taylor & Francis Journals, vol. 12(1), pages 89-93, January.
    • Handle: RePEc:taf:rpsyxx:v:12:y:2020:i:1:p:89-93
    DOI: 10.1080/17522439.2020.1722734
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1080/17522439.2020.1722734
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1080/17522439.2020.1722734?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:rpsyxx:v:12:y:2020:i:1:p:89-93. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Longhurst (email available below). General contact details of provider: http://www.tandfonline.com/RPSY20 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.